Optical and multimodal peptide-based probes for in vivo molecular imaging

Laura Melendez-Alafort, Pier Carlo Muzzio, Antonio Rosato

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Molecular imaging consists of non-invasive monitoring of spatial-temporal distribution of molecular or cellular processes, and may be used for early disease detection and real-time monitoring of therapeutic responses. Several strategies have been developed over the last two decades. Early attempts used monoclonal antibodies or antibody fragments and, although specific targeting was achieved, these probes was largely unsuccessful. In the quest for better agents, labeled peptides were then used. Peptides are easier to synthesize, less likely to be immunogenic, and have rapid blood clearance, which results in adequate target-to-background ratios in a short period of time. This review discusses state-of-the-art cancer imaging by means of labeled peptides, the radionuclide, optical and nanoplatform-based imaging techniques which can provide functional information of the disease and track biochemical processes in vivo. The advantages and disadvantages of each technique are discussed. Lastly, the emphasis of this paper is on the new multimodal probes which can overcome individual limitations and exploit the individual strengths of the latest molecular imaging techniques.

Original languageEnglish
Pages (from-to)476-499
Number of pages24
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume12
Issue number5
Publication statusPublished - Jun 2012

Fingerprint

Molecular Imaging
Peptides
Biochemical Phenomena
Immunoglobulin Fragments
Radioisotopes
Early Diagnosis
Monoclonal Antibodies
Neoplasms
Therapeutics

Keywords

  • Cancer Imaging
  • In Vivo Molecular Imaging
  • Liposomes
  • MRI Imaging
  • Multimodal Probes
  • Multimodal Targeting
  • Nanoparticles
  • Nanotubes
  • Optical imaging
  • Peptide Hormones
  • Peptide PET Imaging
  • Photoacoustic imaging
  • Quantum Dots
  • Radionuclide Imaging
  • Raman Imaging
  • SPECT Imaging
  • Tumor Targeting

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pharmacology

Cite this

Optical and multimodal peptide-based probes for in vivo molecular imaging. / Melendez-Alafort, Laura; Muzzio, Pier Carlo; Rosato, Antonio.

In: Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, No. 5, 06.2012, p. 476-499.

Research output: Contribution to journalArticle

Melendez-Alafort, Laura ; Muzzio, Pier Carlo ; Rosato, Antonio. / Optical and multimodal peptide-based probes for in vivo molecular imaging. In: Anti-Cancer Agents in Medicinal Chemistry. 2012 ; Vol. 12, No. 5. pp. 476-499.
@article{bb29bb1a9f8e4f9381e95310acac02a3,
title = "Optical and multimodal peptide-based probes for in vivo molecular imaging",
abstract = "Molecular imaging consists of non-invasive monitoring of spatial-temporal distribution of molecular or cellular processes, and may be used for early disease detection and real-time monitoring of therapeutic responses. Several strategies have been developed over the last two decades. Early attempts used monoclonal antibodies or antibody fragments and, although specific targeting was achieved, these probes was largely unsuccessful. In the quest for better agents, labeled peptides were then used. Peptides are easier to synthesize, less likely to be immunogenic, and have rapid blood clearance, which results in adequate target-to-background ratios in a short period of time. This review discusses state-of-the-art cancer imaging by means of labeled peptides, the radionuclide, optical and nanoplatform-based imaging techniques which can provide functional information of the disease and track biochemical processes in vivo. The advantages and disadvantages of each technique are discussed. Lastly, the emphasis of this paper is on the new multimodal probes which can overcome individual limitations and exploit the individual strengths of the latest molecular imaging techniques.",
keywords = "Cancer Imaging, In Vivo Molecular Imaging, Liposomes, MRI Imaging, Multimodal Probes, Multimodal Targeting, Nanoparticles, Nanotubes, Optical imaging, Peptide Hormones, Peptide PET Imaging, Photoacoustic imaging, Quantum Dots, Radionuclide Imaging, Raman Imaging, SPECT Imaging, Tumor Targeting",
author = "Laura Melendez-Alafort and Muzzio, {Pier Carlo} and Antonio Rosato",
year = "2012",
month = "6",
language = "English",
volume = "12",
pages = "476--499",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Optical and multimodal peptide-based probes for in vivo molecular imaging

AU - Melendez-Alafort, Laura

AU - Muzzio, Pier Carlo

AU - Rosato, Antonio

PY - 2012/6

Y1 - 2012/6

N2 - Molecular imaging consists of non-invasive monitoring of spatial-temporal distribution of molecular or cellular processes, and may be used for early disease detection and real-time monitoring of therapeutic responses. Several strategies have been developed over the last two decades. Early attempts used monoclonal antibodies or antibody fragments and, although specific targeting was achieved, these probes was largely unsuccessful. In the quest for better agents, labeled peptides were then used. Peptides are easier to synthesize, less likely to be immunogenic, and have rapid blood clearance, which results in adequate target-to-background ratios in a short period of time. This review discusses state-of-the-art cancer imaging by means of labeled peptides, the radionuclide, optical and nanoplatform-based imaging techniques which can provide functional information of the disease and track biochemical processes in vivo. The advantages and disadvantages of each technique are discussed. Lastly, the emphasis of this paper is on the new multimodal probes which can overcome individual limitations and exploit the individual strengths of the latest molecular imaging techniques.

AB - Molecular imaging consists of non-invasive monitoring of spatial-temporal distribution of molecular or cellular processes, and may be used for early disease detection and real-time monitoring of therapeutic responses. Several strategies have been developed over the last two decades. Early attempts used monoclonal antibodies or antibody fragments and, although specific targeting was achieved, these probes was largely unsuccessful. In the quest for better agents, labeled peptides were then used. Peptides are easier to synthesize, less likely to be immunogenic, and have rapid blood clearance, which results in adequate target-to-background ratios in a short period of time. This review discusses state-of-the-art cancer imaging by means of labeled peptides, the radionuclide, optical and nanoplatform-based imaging techniques which can provide functional information of the disease and track biochemical processes in vivo. The advantages and disadvantages of each technique are discussed. Lastly, the emphasis of this paper is on the new multimodal probes which can overcome individual limitations and exploit the individual strengths of the latest molecular imaging techniques.

KW - Cancer Imaging

KW - In Vivo Molecular Imaging

KW - Liposomes

KW - MRI Imaging

KW - Multimodal Probes

KW - Multimodal Targeting

KW - Nanoparticles

KW - Nanotubes

KW - Optical imaging

KW - Peptide Hormones

KW - Peptide PET Imaging

KW - Photoacoustic imaging

KW - Quantum Dots

KW - Radionuclide Imaging

KW - Raman Imaging

KW - SPECT Imaging

KW - Tumor Targeting

UR - http://www.scopus.com/inward/record.url?scp=84861661526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861661526&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 476

EP - 499

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 5

ER -